| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.1M | — |
| Cost of Revenue | $594K | — |
| Gross Profit | $488K | — |
| R&D Expense | $67.0M | -7.0% |
| SG&A Expense | $44.6M | +5.5% |
| Operating Income | -$111.2M | +10.2% |
| Pre-tax Income | -$96.0M | +27.5% |
| Income Tax | $0 | — |
| Net Income | -$96.0M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $133.9M | +58.8% |
| Accounts Receivable | $368K | — |
| Inventory | $3.9M | — |
| Current Assets | $266.3M | -25.6% |
| Total Assets | $298.3M | -23.8% |
| Current Liabilities | $11.6M | -26.1% |
| Total Liabilities | $26.6M | -18.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$94.0M | -3.8% |
| Capital Expenditures | $4.5M | -58.0% |
| Investing Cash Flow | $143.4M | +4.6% |
| Financing Cash Flow | $149K | -92.2% |
| Free Cash Flow | -$98.5M | +2.7% |
| EPS (Basic) | -$0.68 | +28.4% |
| EPS (Diluted) | -$0.68 | +28.4% |
| Stockholders' Equity |
| $271.6M |
| -24.3% |